Schedule 13G ownership disclosure

AKERO THERAPEUTICS INC

Ordinary Shares · CUSIP: 00973Y108

Event date: 2025-06-30

Filing-level shares
6,738,556
Percent of class
8.5%
  • JANUS HENDERSON GROUP PLC

    Shares: 6,738,556 · Class: 8.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000226
Form type
SCHEDULE 13G/A
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub